RxDoctor Payments Data

Jamie House, MD

Physical Medicine & Rehabilitation · Coeur D Alene, IDNPI 1205816782

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Medtronic at 27.2% of the total.

$1,469in general payments, 2019–2025

Across 46 payments — averaging $31.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$400
  • Piramal Critical Care$374
  • AbbVie$293
  • Avanir Pharmaceuticals, Inc.$165
  • Dentsply IH AB$86
  • Coloplast$30
  • plus $120 from 7 others

What the payments were for

  • Food & beverage$1,469100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)8$400
Piramal Critical Care8$374
AbbVie(2 entities)16$293
Avanir Pharmaceuticals, Inc.4$165
Dentsply IH AB1$86
Coloplast2$30
GRT US Holding, Inc.1$24
Smith+Nephew1$20
Lundbeck LLC1$17
Ipsen Biopharmaceuticals, Inc1$17
Amgen1$16
C. R. Bard, Inc. & Subsidiaries1$14
Saol Therapeutics Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,469 in reported general payments places this provider in the 75th percentile of 38 physical medicine & rehabilitation providers in Idaho.

See all physical medicine & rehabilitation providers in Idaho

Medicare billing

Part B allowed, 2024
$48,689
Medicare patients
154
Services billed
967

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BotoxOnabotulinumtoxina88$176,304
MyrbetriqMirabegron69$33,436
GablofenBaclofen18$22,087
Baclofen274$5,813
Modafinil16$3,144
Tizanidine Hcl27$953
Gabapentin36$941
Divalproex Sodium11$586
Duloxetine Hcl11$311
Trazodone Hcl32$277
Pregabalin11$214
Tamsulosin Hcl23$126
Diazepam16$33

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieBotox$293$176,30488 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 38 physical medicine & rehabilitation providers in Idaho.

Other physical medicine & rehabilitation in Coeur D Alene

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →